No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Administration, Oral
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Capecitabine
-
Colorectal Neoplasms / drug therapy*
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives*
-
Diarrhea / chemically induced
-
Drug Combinations
-
Fluorouracil / analogs & derivatives
-
Humans
-
Leucovorin / administration & dosage
-
Nausea / chemically induced
-
Survival Rate
-
Tegafur / adverse effects
-
Tegafur / therapeutic use*
-
Time Factors
-
Uracil / adverse effects
-
Uracil / therapeutic use*
Substances
-
Antineoplastic Agents
-
Drug Combinations
-
Deoxycytidine
-
Tegafur
-
Uracil
-
Capecitabine
-
Leucovorin
-
Fluorouracil